SPECT Biomarker Ctte
Project Snapshot
The SPECT Biomarker Committee seeks to develop a quantitative imaging profile for SPECT imaging.
Under consideration:
- quantifying a small structure (like the basal ganglion in the DaTscan, thyroid)
- quantifying organs, like the liver, for dosimetry as potential use cases
Established Task Forces Currently Working Toward a first Profile with title as follows below:
Quantifying Dopamine Transporters with 123-Iodine labeled Ioflupane in Neurodegenerative Disease
- Image Acquisition and Image Processing for DaTscan – Dr. Dewaraja
- Quantitative / Image Analysis – Drs. Miyaoka and Seibyl
- Phantoms / DRO Group – Drs. Dickson and Zimmerman
- Clinical / Literature Review – Dr. Seibyl
Meetings/Call Summaries
Working Documents
Profile Development
Statistical Reference Documents
Workflow Documents
Reference Materials
- QIBA SPECT BC presentation slides - Dr. Seibyl January 22, 2016
- I-123 DAT SCAN - Acquisition and Reconstruction Task Force presentation slides - Dr. Dewaraja January 5, 2016
- QIBA Claim Statement Types - Dr. Obuchowski November 20, 2015
- 03.20.2015 Link to papers of the group in Umeå that are collaborating with Dr. Ljungberg:
- The PI for this is Anne Larsson, PhD: http://www.ncbi.nlm.nih.gov/pubmed/?term=dat+scan+Larsson+A